IL180703A0 - Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitable for the treatment of neurodegenerative disorders - Google Patents

Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitable for the treatment of neurodegenerative disorders

Info

Publication number
IL180703A0
IL180703A0 IL180703A IL18070307A IL180703A0 IL 180703 A0 IL180703 A0 IL 180703A0 IL 180703 A IL180703 A IL 180703A IL 18070307 A IL18070307 A IL 18070307A IL 180703 A0 IL180703 A0 IL 180703A0
Authority
IL
Israel
Prior art keywords
morpholine
piperazine
piperidine
treatment
neurodegenerative disorders
Prior art date
Application number
IL180703A
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2005/053345 external-priority patent/WO2006008259A1/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL180703A0 publication Critical patent/IL180703A0/en

Links

IL180703A 2004-07-16 2007-01-15 Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitable for the treatment of neurodegenerative disorders IL180703A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58844604P 2004-07-16 2004-07-16
EP04103413 2004-07-16
PCT/EP2005/053345 WO2006008259A1 (en) 2004-07-16 2005-07-13 Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitabale for the treatment of neurodegenerative disorders

Publications (1)

Publication Number Publication Date
IL180703A0 true IL180703A0 (en) 2007-06-03

Family

ID=39243746

Family Applications (1)

Application Number Title Priority Date Filing Date
IL180703A IL180703A0 (en) 2004-07-16 2007-01-15 Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitable for the treatment of neurodegenerative disorders

Country Status (4)

Country Link
JP (1) JP2008506669A (en)
EA (1) EA200700140A1 (en)
IL (1) IL180703A0 (en)
MX (1) MX2007000615A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1809282B1 (en) * 2004-10-18 2013-01-09 Amgen, Inc Thiadiazole compounds and methods of use
ES2549924T3 (en) * 2009-11-25 2015-11-03 Cytometix, Inc. Arachidonic acid analogs and methods for analgesic treatment using the same
US9040712B2 (en) * 2013-01-23 2015-05-26 Novartis Ag Thiadiazole analogs thereof and methods for treating SMN-deficiency-related-conditions
AU2015323817B2 (en) * 2014-09-26 2018-11-01 Astrazeneca Ab 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds and use as SGRM modulators

Also Published As

Publication number Publication date
JP2008506669A (en) 2008-03-06
MX2007000615A (en) 2007-03-07
EA200700140A1 (en) 2007-08-31

Similar Documents

Publication Publication Date Title
IL178648A0 (en) Substituted morpholine compounds for the treatment of central nervous system disorders
LTC1869025I2 (en) Piperazine replaced benzothiophenes for the treatment of mental disorders
IL180680A0 (en) Piperazine derivatives useful for the treatment of gastrointestinal disorders
HUS1500058I1 (en) Pharmaceutical combinations containing benzoxazine for treating respiratory diseases
AP2379A (en) Imidazole compounds for the treatment of neurodegenerative disorders.
HK1152952A1 (en) Combination therapy for cell disorders
EP1833467A4 (en) Pharmaceutical compositions for sleep disorders
ZA200706791B (en) Isoxazole combretasin derivatives for the treatment of disorders
IL190652A0 (en) Novel pharmaceutical combinations for the treatment of respiratory disorders
PL1801108T3 (en) Morpholine compounds for the treatment of inflammations
IL177955A0 (en) Sulfonamide compounds for the treatment of neurodegenerative disorders
EP1658072A4 (en) Compounds for the treatment of neurodegenerative disorders
IL180703A0 (en) Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitable for the treatment of neurodegenerative disorders
TWI350753B (en) 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of pain
GB0604780D0 (en) Use of substituted piperazine compounds for the treatment of food related disorders
TWI340643B (en) 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of movement disorders
PL1727545T3 (en) Use of n-piperidine derivatives for the treatment of neurodegenerative pathologies
HK1130433A1 (en) Piperidine and piperazine derivatives
IL188104A0 (en) Compounds useful for treating bipolar disorders